Biberach an der Riss, Germany

Armin Heckel

USPTO Granted Patents = 63 

 

 

Average Co-Inventor Count = 5.2

ph-index = 11

Forward Citations = 403(Granted Patents)

Forward Citations (Not Self Cited) = 366(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • late of Biberach, DE (1995)
  • Biberach, DE (1987 - 2018)
  • Biberach an der Riss, DE (2014 - 2021)

Company Filing History:


Years Active: 1987-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Benzimidazolium Compounds
Heterocyclic Compounds
Pharmaceutical Compositions
Indolinone Derivatives
Pyrazine Amide Compounds
Sulfoximine Substituted Quinazolines
Triazole Benzamide Derivatives
Respiratory Disease Treatments
Fibrotic Disease Medicaments
Epithelial Sodium Channel Inhibitors
Kinase Inhibitory Activity
Immunologic Disease Treatments
63 patents (USPTO):Explore Patents

Title: The Innovative Journey of Armin Heckel: Pioneering Inventor in Biberach an der Riss

Introduction:

Armin Heckel, a distinguished inventor based in Biberach an der Riss, Germany, has left an indelible mark in the field of pharmaceutical innovations. With an impressive portfolio of 63 patents, his groundbreaking work has significantly impacted the treatment and prevention of diseases, particularly in the realm of type 2 diabetes.

Latest Patents:

Armin Heckel's latest patents showcase his ingenuity and commitment to advancing pharmacological research. His inventions include Triazole benzamide derivatives as GPR142 agonists, which have shown promising potential in targeting the GPR142 receptor to modulate its activity for disease management. Additionally, his work on annelated phenoxyacetamides underscores his dedication to developing novel compounds for medicinal purposes.

Career Highlights:

Armin Heckel has contributed his expertise to renowned companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma KG. During his tenure at these organizations, he has spearheaded numerous research projects that have led to the development of pioneering pharmaceutical solutions.

Collaborations:

Throughout his career, Armin Heckel has collaborated closely with esteemed professionals in the field. Some of his notable coworkers include Joerg Kley and Gerald Juergen Roth, who have collectively worked towards achieving innovative breakthroughs in pharmaceutical science.

Conclusion:

In conclusion, Armin Heckel's unwavering dedication to innovation and his remarkable contributions to the field of pharmacology stand as a testament to his visionary approach towards inventing solutions that have the potential to transform healthcare. His legacy as an inventive luminary in Biberach an der Riss continues to inspire future generations of inventors and researchers in the pursuit of groundbreaking discoveries and advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…